课题基金 / 基金详情

1Treatment of Cholestatic Pruritus With Sertraline

1Treatment of Cholestatic Pruritus With Sertraline
1舍曲林治疗胆汁淤积性瘙痒症
批准号:
6728266
负责人:
MARLYN J MAYO
金额:
$15.6万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2006-03-31

项目摘要

项目成果

MARLYN J MAYO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objective of this proposal is to improve the health and quality of life of patients with primary biliary cirrhosis (PBC) and other disorders that cause pruritus. The immediate, short-term objective of this proposal is to determine the safety and efficacy of sertraline as a treatment for cholestatic pruritus. The hypothesis of this proposal, which is based on the previous observation that some patients with PBC have experienced resolution of their pruritus when given sertraline, is that sertraline therapy will improve the symptom of cholestatic pruritus. The specific aims are: 1) to determine the optimal dose and time to response of sertraline treatment for cholestatic pruritus 2) to determine the tolerability of sertraline in patients with reduced liver function. The secondary aims of this proposal will be to evaluate the effect of sertraline on cholestatic pruritus and to determine how changes in pruritus are related to changes in depressive symptoms or plasma sertraline/desmethylsertraline levels. The health relatedness of the project is the potential to identify an innovative, more effective, and better-tolerated treatment of cholestatic pruritus. Patients with cholestatic liver disease often suffer from disabling pruritus. Current treatments are not always effective, and liver transplantation is sometimes necessary to alleviate the pruritus. Quality of life is significantly impaired by chronic pruritus. The method to be used in the proposal is a clinical therapeutic trial of sertraline in patients with pruritus due to either PBC or chronic hepatitis C. The research design is divided into two parts. In first part (A), subjects with cholestatic pruritus will undergo an unblinded dose escalation of sertraline. Part B of the study will consist of a double-blind, randomized, placebo-controlled, crossover study of the efficacy of sertraline. Data regarding pruritus symptoms and side effects of sertraline will be collected and analyzed to determine the safety and efficacy of sertraline used in this setting. These studies will serve as pilot trials. The results of this proposed project will be used to design a larger controlled trial that could be proposed for funding through an R01 mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY BILIARY CIRRHOSIS
  • 批准号:
    7606304
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    2007
  • 负责人:
    MARLYN J MAYO
  • 依托单位:
TREATMENT OF METABOLIC PRURITIS
  • 批准号:
    7606318
  • 项目类别:
  • 资助金额:
    $0.01万
  • 财政年份:
    2007
  • 负责人:
    MARLYN J MAYO
  • 依托单位:
UDCA AMP; METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
  • 批准号:
    7606305
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2007
  • 负责人:
    MARLYN J MAYO
  • 依托单位:
UDCA & METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
  • 批准号:
    7377596
  • 项目类别:
  • 资助金额:
    $2.54万
  • 财政年份:
    2006
  • 负责人:
    MARLYN J MAYO
  • 依托单位:
海外基金